In focus · trending topic

Serious skin infections

2 stories · following the connections

Melinta Therapeutics Publication Reinforces Baxdela Tolerability and Activity in Patients with MRSA Infections and Challenging Comorbidities

By Nasdaq OMXOct 24, 2017, 12:01 PM UTC

Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

By Nasdaq OMXJun 19, 2017, 8:30 PM UTC